Cerebrolysin protects PC12 cells from CoCl2-induced hypoxia employing GSK3β signaling

Article OPEN
Hartwig, Kerstin; Fackler, Viktoria; Jaksch-Bogensperger, Heidi; Furtner, Tanja; Couillard-Despres, Sébastien; Meier, Dieter; Moessler, Herbert; Winter, Stefan; Aigner, Ludwig;
(2014)

Cerebrolysin (EVER Neuro Pharma, Austria) is a peptidergic drug indicated for clinical use in stroke, traumatic brain injury and dementias. The therapeutic effect of Cerebrolysin is thought to ensure from its neurotrophic activity, which shares some properties with natu... View more
Share - Bookmark

  • Download from
    ZENODO via ZENODO (Article, 2014)
  • Funded by
  • Cite this publication